Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation
Completed · Not applicable
Conditions studied: Atrial Fibrillation
In brief
The overall goal is to improve outcomes among patients with atrial fibrillation (AF) by preventing stroke. The investigators propose to implement an automated algorithm using electronic medical record (EMR) data to alert physicians in a large primary care practice network at the Massachusetts General Hospital (MGH) of their patients with AF and elevated stroke risk that are not taking an anticoagulant for stroke prevention. The investigators hypothesize that interventions to notify physicians of such individuals may prompt reassessment for the need for anticoagulation, and thereby increase guideline-indicated anticoagulation rates. Additionally, in a survey component, physicians will characterize reasons for not pursuing anticoagulation in AF patients at elevated risk for stroke.
Key facts
- Study ID
- NCT02950285
- Run by
- Massachusetts General Hospital
- People needed
- 2336
- Starts
- 2017-02-07
- Expected to finish
- 2017-05-07
- Last updated by the study team
- 2017-06-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients 18 and older seen in Massachusetts General Hospital primary care practices in the past 3 years
- Diagnosed with atrial fibrillation
- Increased risk of stroke (CHA2DS2VASc score ≥ 2)
- Not currently taking an anticoagulant
You may not qualify if…
- Patients who are subsequently identified as having died prior to or during the course of the study intervention using the Social Security Death Index
- Listed in the Massachusetts General Hospital system as having a PCP outside of the network
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.